William Grossman
Interim Chief Medical Officer at enGene Therapeutics Inc. (ENGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$1K
Total bought / sold$10K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 24SEC | ENGNenGene Therapeutics Inc. | Buy | 5,102new position | $1.97 | $10K | -12.2% |
- Buy
Interim Chief Medical Officer William Grossman bought $10K of ENGN at $1.97 — first open-market purchase in our records; opens a new position.